Lux Research (Boston, MA) forecasts that the mobile health market will grow eight-fold from $5.1 billion in 2013 to $41.8 billion in 2023, primarily driven by adoption of vital signs monitoring and in vitro diagnostic (IVD) devices.
Related: The four segments of biophotonics market growth
Clinical mobile health devices will soar past consumer-focused counterparts after a slow start due to regulatory approval barriers and slower integration into physicians' workflows. For instance, clinical vital signs monitoring devices will grow from $372 million in 2013 to $16 billion in 2023, a compound annual growth rate (CAGR) of 46 percent, while consumer applications will grow from $2.5 billion to $7 billion, an 11-percent CAGR.
"Consumer devices have seen a lot of hype but clinical devices will surpass their consumer counterparts in revenues by 2020, helped by value-added software services and generally larger revenue streams," explains Nick Kurkjy, Lux research associate and lead author of the report titled, "mHealth Showdown: Consumer and Clinical Devices' Battle for Market Dominance."
"Clinical markets will be able to pay much more for comparable services, especially if a device is able to reduce patient recovery times or readmission rates, which can lead to outsized cost savings for the health care provider," Kurkjy adds.
Lux Research analysts found that:
- The smartphone boom leads to increased mobile health VC funding. Venture funding for mobile health devices has risen sharply since 2007, reaching $480 million in 2013.
- IVD and vital signs spaces make up 75 percent of the mobile health device market by 2023. The considerable growth of the mobile health device market will be largely driven by the vital signs and IVD sectors. The analysts project that these two will combine to make a $32.9 billion market by 2023.
- Vertical integration is coming. Large players from both electronics and medical device industries are starting to make acquisitions. Covidien's purchase of Zephyr Technologies and Intel's acquisition of Basis are among the most recent moves, as major companies look to stake their claims.
For more information, please visit https://portal.luxresearchinc.com/research/report/17093.
Don't miss Strategies in Biophotonics, a conference and exhibition dedicated to development and commercialization of bio-optics and biophotonics technologies!
Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn
Subscribe now to BioOptics World magazine; it's free!